SE8902532L - Bestaemning av plasmaproteiner - Google Patents

Bestaemning av plasmaproteiner

Info

Publication number
SE8902532L
SE8902532L SE8902532A SE8902532A SE8902532L SE 8902532 L SE8902532 L SE 8902532L SE 8902532 A SE8902532 A SE 8902532A SE 8902532 A SE8902532 A SE 8902532A SE 8902532 L SE8902532 L SE 8902532L
Authority
SE
Sweden
Prior art keywords
pct
determination
plasma proteins
sec
protein
Prior art date
Application number
SE8902532A
Other languages
Unknown language ( )
English (en)
Other versions
SE464135B (sv
SE8902532D0 (sv
Inventor
S Rosen
Original Assignee
Kabivitrum Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kabivitrum Ab filed Critical Kabivitrum Ab
Priority to SE8902532A priority Critical patent/SE464135B/sv
Publication of SE8902532D0 publication Critical patent/SE8902532D0/sv
Priority to DK90910954.8T priority patent/DK0486515T3/da
Priority to US07/793,342 priority patent/US5439802A/en
Priority to ES90910954T priority patent/ES2079481T3/es
Priority to DE69022425T priority patent/DE69022425T2/de
Priority to JP2510438A priority patent/JP2892828B2/ja
Priority to CA002063564A priority patent/CA2063564A1/en
Priority to IE243190A priority patent/IE902431A1/en
Priority to AT90910954T priority patent/ATE127853T1/de
Priority to EP90910954A priority patent/EP0486515B1/en
Priority to PCT/SE1990/000478 priority patent/WO1991001382A1/en
Priority to AU60533/90A priority patent/AU6053390A/en
Publication of SE8902532L publication Critical patent/SE8902532L/sv
Publication of SE464135B publication Critical patent/SE464135B/sv
Priority to NO92920125A priority patent/NO920125L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2337/00—N-linked chromogens for determinations of peptidases and proteinases
    • C12Q2337/10—Anilides
    • C12Q2337/12—Para-Nitroanilides p-NA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/4609—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates from reptiles
    • G01N2333/4613—Snake venom
    • G01N2333/462—Snake venom from Agkistrodon sp., e.g. acutase, ACTE
    • G01N2333/4626—Snake venom from Agkistrodon sp., e.g. acutase, ACTE from Agkistrodon contortrix contortrix (copperhead snake); Protac (R)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/745—Assays involving non-enzymic blood coagulation factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/9645—Factor IX (3.4.21.22)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96461—Protein C (3.4.21.69)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974—Thrombin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8902532A 1989-07-14 1989-07-14 Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov SE464135B (sv)

Priority Applications (13)

Application Number Priority Date Filing Date Title
SE8902532A SE464135B (sv) 1989-07-14 1989-07-14 Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov
AU60533/90A AU6053390A (en) 1989-07-14 1990-07-04 A method for determining the functional activity of free protein s or protein c in a plasma sample
CA002063564A CA2063564A1 (en) 1989-07-14 1990-07-04 Method for determining the functional activity of free protein s or protein c in a plasma sample
AT90910954T ATE127853T1 (de) 1989-07-14 1990-07-04 Verfahren zur bestimmung der funktionellen wirkung von freiem protein s oder protein c in einer plasmaprobe.
ES90910954T ES2079481T3 (es) 1989-07-14 1990-07-04 Un procedimiento para la determinacion de la actividad funcional de la proteina s o de la proteina c libre en una muestra de plasma.
DE69022425T DE69022425T2 (de) 1989-07-14 1990-07-04 Verfahren zur Bestimmung der funktionellen Wirkung von freiem Protein S oder Protein C in einer Plasmaprobe.
JP2510438A JP2892828B2 (ja) 1989-07-14 1990-07-04 血漿プロテインの検定方法
DK90910954.8T DK0486515T3 (da) 1989-07-14 1990-07-04 Fremgangsmåde til bestemmelse af den funktionelle aktivitet af frit protein S eller protein C i en plasmaprøve
IE243190A IE902431A1 (en) 1989-07-14 1990-07-04 Assaying of plasma proteins
US07/793,342 US5439802A (en) 1989-07-14 1990-07-04 Method for determining the functional activity of free protein S or protein C in a plasma sample
EP90910954A EP0486515B1 (en) 1989-07-14 1990-07-04 A method for determining the functional activity of free protein S or protein C in a plasma sample
PCT/SE1990/000478 WO1991001382A1 (en) 1989-07-14 1990-07-04 A method for determining the functional activity of free protein s or protein c in a plasma sample
NO92920125A NO920125L (no) 1989-07-14 1992-01-09 Fremgangsmaate for aa bestemme den funksjonelle aktivitetentil fritt protein s eller protein c i en plasmaproeve

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8902532A SE464135B (sv) 1989-07-14 1989-07-14 Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov

Publications (3)

Publication Number Publication Date
SE8902532D0 SE8902532D0 (sv) 1989-07-14
SE8902532L true SE8902532L (sv) 1991-01-15
SE464135B SE464135B (sv) 1991-03-11

Family

ID=20376547

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8902532A SE464135B (sv) 1989-07-14 1989-07-14 Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov

Country Status (13)

Country Link
US (1) US5439802A (sv)
EP (1) EP0486515B1 (sv)
JP (1) JP2892828B2 (sv)
AT (1) ATE127853T1 (sv)
AU (1) AU6053390A (sv)
CA (1) CA2063564A1 (sv)
DE (1) DE69022425T2 (sv)
DK (1) DK0486515T3 (sv)
ES (1) ES2079481T3 (sv)
IE (1) IE902431A1 (sv)
NO (1) NO920125L (sv)
SE (1) SE464135B (sv)
WO (1) WO1991001382A1 (sv)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4006634A1 (de) * 1990-03-03 1991-09-05 Behringwerke Ag Funktioneller test zur bestimmung der protein s-aktivitaet
US5716795A (en) * 1991-10-04 1998-02-10 Matschiner; John T. Thrombomodulin-based coagulometric assay of the protein C system
AU2870992A (en) * 1991-10-04 1993-05-03 Board Of Regents Of The University Of Nebraska, The A soluble thrombomodulin-based one-stage assay for vitamin k-dependent coagulation-inhibiting proteins
ATE163768T1 (de) * 1991-10-04 1998-03-15 Dade Int Inc Herstellung von prothrombinzeit-reagenzien aus rekombinantem menschlichem gewebefaktor und sythetischen phospholipiden
SE470274B (sv) * 1991-11-13 1993-12-20 Bjoern Dahlbaeck Användning av en in vitro-metod för diagnos av blodkoagulationssjukdomar
ATE132909T1 (de) * 1991-11-13 1996-01-15 Bjoern Dahlbaeck Vefahren zur diagnose von störungen der blutgerinnung
US5308756A (en) * 1991-11-20 1994-05-03 Baxter Diagnostics Inc. Protein S chromogenic assay
DE4229933A1 (de) * 1992-09-08 1994-03-10 Max Planck Gesellschaft Verfahren zur Bestimmung von Thrombose verursachenden Lupus-anticoagulant-Antikörpern
EP0690991B2 (en) * 1993-01-29 2004-01-14 T.A.C. Thrombosis and Coagulation Aktiebolag Novel anticoagulant cofactor activity
DE59410041D1 (de) * 1993-12-03 2002-03-21 Baxter Ag Test zur Bestimmung der Empfindlichkeit gegenüber aktiviertem Protein C
AUPM731394A0 (en) * 1994-08-05 1994-09-01 Life Therapeutics Limited Improved activated protein c resistance test
DE4427785A1 (de) * 1994-08-08 1996-02-15 Behringwerke Ag Verfahren zum Nachweis von Störungen des Protein C/Protein S-Systems
SE9403833D0 (sv) * 1994-11-08 1994-11-08 Global Hemostasis Inst Mgr Ab Analysförfarande och kit
US5780255A (en) * 1995-06-09 1998-07-14 Instrumentation Laboratory, S.P.A. Protein C pathway screening test
US5766869A (en) * 1995-11-30 1998-06-16 Ahs Hospital Corp. Factor V ratio blood test for susceptibility to thromboembolism
US6379975B1 (en) 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
SE9701228D0 (sv) * 1997-04-03 1997-04-03 Bjoern Dahlbaeck Rekombinanta protein-C-och protein-S-varianter
AUPP159698A0 (en) 1998-02-02 1998-02-26 Life Therapeutics Limited Improved blood coagulation test
PT947585E (pt) 1998-03-19 2001-11-30 Instrumentation Lab Spa Metodo in vitro melhorado, kits e reagentes para a peaquisa de defeitos de coagulacao sanguinea
US6855509B2 (en) 2000-12-19 2005-02-15 Instrumentation Laboratory Company Protein S functional assay and kit therefor
JP5839256B2 (ja) 2011-03-14 2016-01-06 学校法人九州文化学園 総プロテインｓ異常症の検出方法において用いる試薬
CN106153612A (zh) * 2015-12-04 2016-11-23 上海贞元诊断用品科技有限公司 抗凝血酶活性检测试剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657894A (en) * 1983-03-31 1987-04-14 Scripps Clinic & Research Foundation New factor VIII coagulant polypeptides
DE3516579A1 (de) * 1984-11-19 1986-05-22 Boehringer Mannheim Gmbh, 6800 Mannheim Gerinnungstest auf teststreifen
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
DE3607559A1 (de) * 1986-03-07 1987-09-10 Boehringer Mannheim Gmbh Verfahren zur photometrischen bestimmung der protein c- und/oder protein s-aktivitaet
US4908314A (en) * 1987-07-02 1990-03-13 American National Red Cross Protein C activator
DE3724443A1 (de) * 1987-07-23 1989-02-02 Max Planck Gesellschaft Funktioneller test zur bestimmung der protein s-aktivitaet
JP2739050B2 (ja) * 1988-01-28 1998-04-08 ヘキスト薬品工業株式会社 抗血液凝固剤
US5051357A (en) * 1989-07-14 1991-09-24 Board Of Trustees Operating Michigan State University Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor

Also Published As

Publication number Publication date
NO920125D0 (no) 1992-01-09
SE464135B (sv) 1991-03-11
ATE127853T1 (de) 1995-09-15
IE902431A1 (en) 1991-06-19
JP2892828B2 (ja) 1999-05-17
EP0486515B1 (en) 1995-09-13
AU6053390A (en) 1991-02-22
WO1991001382A1 (en) 1991-02-07
ES2079481T3 (es) 1996-01-16
CA2063564A1 (en) 1991-01-15
DE69022425T2 (de) 1996-05-02
US5439802A (en) 1995-08-08
NO920125L (no) 1992-01-09
SE8902532D0 (sv) 1989-07-14
DE69022425D1 (de) 1995-10-19
JPH04506603A (ja) 1992-11-19
DK0486515T3 (da) 1996-01-29
EP0486515A1 (en) 1992-05-27

Similar Documents

Publication Publication Date Title
SE8902532L (sv) Bestaemning av plasmaproteiner
WO1998033509A3 (en) Useful properties of human lactoferrin and variants thereof
DK0960127T3 (da) Isoleret dimert fibroblastaktiverende protein-alfa og anvendelser deraf
WO1995021601A3 (en) Kallikrein-inhibiting 'kunitz domain' proteins and analogues thereof
MY102472A (en) Preparation of funtional human urokinase proteins.
DE69922822D1 (de) Rekombinante haarbehandlungsmittel
DE3587875D1 (de) Rekombinantverfahren zur herstellung von serinproteaseinhibitoren, sowie dns-sequenzen dazu.
FI972703A0 (sv) Rekombinat IL-5-antagonister användbara vid behandling av IL-5-relaterade sjukdomar
ATE186121T1 (de) Verfahren zur bestimmung des präthrombotischen status
HUP9900506A2 (hu) Protrombinszármazékok
DE3852625D1 (de) Vektoren und Verbindungen zur Expression von Zymogen-Formen von menschlichem Protein C.
ATE310828T1 (de) Implantat und vektor zur behandlung von erworbenen krankheiten
PT723552E (pt) Oligopeptidos derivados de fragmentos de proteina reactiva c
DK0649433T3 (da) Antigeniske regioner fra komplekser af tumorfrigivne partikler (TLP) og antistoffer mod sådanne.
ATE312179T1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
DK0870036T3 (da) Syntetisk pattedyrs-alfa-N-acetylglucosaminidase og genetiske sekvenser kodende derfor
ATE312914T1 (de) Rdgb-proteine
NO992531L (no) Fremgangsmåter ved fremstilling av rekombinant protein
NZ514691A (en) Method to type prion proteins
DE69825307D1 (de) Verwendung von protein h als zytostattischer wirkstoff
NO874320D0 (no) Fremgangsmaate for bestemmelse av funksjonelle nivaaer av protein c i humant plasma.
TR200003184T2 (tr) ''İnsülin benzeri büyüme faktörünü bağlayan proteinin selektif klivajını yapabilen yeni serin proteazı''
FR2623628B1 (fr) Serum etalon, de nature humaine, reconstitue a partir des fractions rejetees (non utilisees en therapeutique), du fractionnement du plasma humain, du sang humain, du sang placentaire ou retroplacentaire
DE3873255D1 (de) Methoden und praeparate zur vorbeugung von ulcera.

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8902532-4

Effective date: 19930204

Format of ref document f/p: F